Overview

Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer

Status:
Completed
Trial end date:
2019-09-20
Target enrollment:
Participant gender:
Summary
This pilot study focuses on KD018 and will investigate the effect of this agent on reducing the Gastrointestinal (GI) toxicity associated with combined modality therapy of locally-advanced rectal cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Yale University
Treatments:
Capecitabine